Vatican Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Health Times.

Press releases published on August 27, 2026

10 hours ago

BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation

Indeterminate GlobeNewswire

10 hours ago

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial

Indeterminate GlobeNewswire

10 hours ago

Nexalin Technology Announces Reverse Stock Split

Indeterminate GlobeNewswire

10 hours ago

HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System

Indeterminate GlobeNewswire

10 hours ago

NovaBridge Biosciences to Participate in September Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

Velocity Clinical Research Establishes a New Industry Benchmark, Entering 97% of Patient Data Within 24 Hours of Collection

Indeterminate GlobeNewswire

10 hours ago

Korro to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

Aveanna to Participate in the Deutsche Bank 2026 Healthcare Summit

Indeterminate GlobeNewswire

10 hours ago

Slate Medicines Announces First Participant Dosed in Phase 1 Study Evaluating SLTE-1009

Indeterminate GlobeNewswire

10 hours ago

NetraMark to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

10 hours ago

Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference

Indeterminate GlobeNewswire

14 hours ago

Umbrella Lab Announces Documentation and Traceability Update For S-4 Andarine Reference Material

Indeterminate GlobeNewswire

14 hours ago

Osivax and GC Biopharma Enter Strategic Collaboration to Develop a Next-Generation Influenza Vaccine Combining OVX836 and GC FLU

Indeterminate GlobeNewswire

16 hours ago

A decade of profitability provides foundation for CLINUVEL’s U.S. expansion

Indeterminate GlobeNewswire

16 hours ago

Nicox Announces April 2027 PDUFA Date for NCX 470 in Glaucoma

Indeterminate GlobeNewswire

16 hours ago

Nicox annonce avril 2027 comme date PDUFA pour NCX 470 dans le traitement du glaucome

Indeterminate GlobeNewswire

17 hours ago

Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Aug. 27, 2026

Mesoblast Reports Substantial Revenue Growth to US$120M

Indeterminate GlobeNewswire